ABSTRACT
Atrial myxoma is the most common benign tumor of the heart, but its appearance after radiofrequency ablation is very rare. We report a case in which an asymptomatic, rapidly growing cardiac myxoma arose in the left atrium after radiofrequency ablation. Two months after the procedure, cardiovascular magnetic resonance, performed to evaluate the right ventricular anatomy, revealed a 10 × 10-mm mass (assumed to be a thrombus) attached to the patient's left atrial septum. Three months later, transthoracic echocardiography revealed a larger mass, and the patient was diagnosed with myxoma. Two days later, a 20 × 20-mm myxoma weighing 37 g was excised. To our knowledge, the appearance of an atrial myxoma after radiofrequency ablation has been reported only once before. Whether tumor development is related to such ablation or is merely a coincidence is uncertain, but myxomas have developed after other instances of cardiac trauma.
Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/adverse effects , Cell Proliferation , Heart Neoplasms/etiology , Myxoma/etiology , Atrial Fibrillation/diagnosis , Atrial Septum/pathology , Echocardiography, Transesophageal , Heart Neoplasms/pathology , Heart Neoplasms/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Myxoma/pathology , Myxoma/surgery , Reoperation , Time Factors , Tumor BurdenSubject(s)
Calcinosis/diagnosis , Cardiomyopathies/diagnosis , Pericardiectomy/methods , Pericardium , Adult , Calcinosis/surgery , Cardiomyopathies/surgery , Diagnosis, Differential , Echocardiography , Female , Follow-Up Studies , Humans , Imaging, Three-Dimensional , Severity of Illness Index , Tomography, X-Ray ComputedABSTRACT
Biological glue is increasingly used in cardiac surgery. We report a case of type A aortic dissection repair that was complicated by subsequent pulmonary embolism due to BioGlue(®) (Cryolife Inc, Hennesaw, GA, USA). To our knowledge this is the first report of a case with this complication.
Subject(s)
Aortic Aneurysm/surgery , Aortic Dissection/surgery , Blood Vessel Prosthesis Implantation , Proteins/adverse effects , Pulmonary Embolism/chemically induced , Tissue Adhesives/adverse effects , Aged , Aneurysm, False/etiology , Aortic Rupture/etiology , Blood Vessel Prosthesis Implantation/adverse effects , Fatal Outcome , Humans , Male , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/surgery , Reoperation , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Long-term survival was investigated in 202 patients who underwent isolated aortic valve replacement (AVR) with 19 mm valves. There were 171 women with a mean age of 69+/-9 years and 31 men with a mean age of 64+/-13 years. Patients had a mean body surface area of 1.61+/-0.13 m(2). Patient-prosthesis mismatch was moderate in 196 and severe in six patients. The mean follow-up for all patients was 78 months. There were 79 late deaths. The actuarial survival rates for all patients were 95+/-1% at 1 year, 75+/-2% at 5 years, 56+/-2% at 10 years, 41+/-2% at 15 years, 34+/-3% at 20 years and 34+/-2% at 25 years. Patients over 70 years old had a lower survival rate (P=0.0001). There were significant differences between ejection fraction (EF) >55% and EF <55% (P=0.0305). AVR with 19 mm valves appeared to provide satisfactory mid-term survival. Age and low EF were risk factors for shorter survival.
Subject(s)
Aortic Valve Stenosis/surgery , Aortic Valve/surgery , Heart Valve Prosthesis Implantation/instrumentation , Heart Valve Prosthesis , Survivors , Adult , Age Factors , Aged , Aged, 80 and over , Aortic Valve/physiopathology , Aortic Valve Stenosis/mortality , Aortic Valve Stenosis/physiopathology , Body Surface Area , Female , Heart Valve Prosthesis Implantation/mortality , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Proportional Hazards Models , Prosthesis Design , Retrospective Studies , Risk Assessment , Risk Factors , Stroke Volume , Time Factors , Treatment Outcome , Ventricular Function, LeftABSTRACT
Immunosuppression can allow organisms that are not usually pathogenetic to cause disease; under such circumstances, Aspergillus species frequently form large masses of fungal elements. We describe the case of a 12-year-old girl with hematologic remission of leukemia. She had a left ventricular pedunculated mass that was detected by echocardiographic study; at surgery, the presence of Aspergillus terreus was confirmed.
